Jean-claude Barbare
Amiens, 80054, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis C.
Journal: Digestive diseases and sciences
Published: April 08, 2019
Early decrease in serum amphiregulin or vascular endothelial growth factor levels predicts sorafenib efficacy in hepatocellular carcinoma.
Journal: Oncology reports
Published: June 29, 2018
Care pathway of patients with hepatocellular carcinoma in France: State of play in 2017
Journal: Bulletin du cancer
Published: April 12, 2017
Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: August 23, 2016
Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib.
Journal: Cancer letters
Published: September 10, 2015
Biomarkers of apoptosis and necrosis in patients with hepatocellular carcinoma treated with sorafenib.
Journal: Anticancer research
Published: March 10, 2015
The endless SEARCH for a better medical treatment of advanced hepatocellular carcinoma.
Journal: Clinics and research in hepatology and gastroenterology
Published: January 08, 2015
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma.
Journal: The oncologist
Published: December 28, 2014
Last Updated: 09/26/2026